CadheRx Therapeutics
Latest round
- Series A
Last raised
- Jun 2015
Total raised
- $10M
Investors
- 2
About CadheRx Therapeutics
CadheRx Therapeutics is based in La Jolla, US. The firm operates as a developer of therapeutic antibodies targeting soluble E-cadherin (sEcad) for the treatment of solid tumors.
Who invested in CadheRx Therapeutics
2 investors across 1 round
See all investors in CadheRx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 15, 2015
Amount
$10M
Investors
Questions about CadheRx Therapeutics
Who invested in CadheRx Therapeutics?
CadheRx Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CadheRx Therapeutics raised?
CadheRx Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CadheRx Therapeutics last raise money?
CadheRx Therapeutics's most recent round on record is a Series A, in Jun 2015.
What does CadheRx Therapeutics do?
CadheRx Therapeutics is based in La Jolla, US.
Where is CadheRx Therapeutics headquartered?
CadheRx Therapeutics is headquartered in US.
Which VCs invest in companies like CadheRx Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CadheRx Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like CadheRx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.